cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.ey7msx
title: Occurrence Download

description: A dataset containing 4674 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Dalatias licha (Bonnaterre, 1788)"
 ]
}

 The dataset includes 4674 records from 112 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002237-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/00004409
title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multicenter Study to Evaluate the Urodynamic Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia

description: The purpose of this study is to evaluate the function of the bladder and urethra during urinary storage or voiding in men with signs and symptoms of benign prostatic hyperplasia treated with either placebo or tadalafil.
DOI: 10.25934/00000422
title: An Open Label, Single Dose, Parallel Group Study to Evaluate Absorption and Transit Characteristics of TREXIMA and RELPAX in Patients Inside and Outside of an Acute Migraine Attack.

description: An evaluation of tablet disintegration and absorption and gastric transit of sumatriptan and naproxen sodium from a TREXIMA tablet and eletriptan from a RELPAX 40mg tablet.
DOI: 10.25934/pr00008351
title: Phase III, Multicentre, Open Study to Assess the Efficacy and Safety Profiles of the Co-administration of Lanreotide Autogel 120 mg (Administered Via Deep Subcutaneous Injections Every 28 Days) and Pegvisomant 40 to 120 mg Per Week (Administered Via Subcutaneous Route Once or Twice a Week) in Acromegalic Patients Failing to Respond to Lanreotide Autogel 120 mg Alone

description: The main aim of this study is to assess the efficacy of the co-administration of lanreotide Autogel 120 mg (administered via deep sub-cutaneous injections every 28 days) and pegvisomant (administered at 40 to 120 mg per week via sub-cutaneous injection given once or twice a week) on IGF-1 levels over 28 weeks in acromegalic patients. The primary endpoint will be the percentage of acromegalic patients with normalised (age and sex adjusted) IGF-1 level at the end of the co-treatment period.
DOI: 10.25934/00000417
title: A Randomised, Double-blind, Placebo-controlled, Dose Ascending, Five-way Crossover Study, to Examine Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of a Single Administration of Three Inhaled Doses (25, 100 and 400 Âµg) of GW642444M

description: This is a study of GW642444M, a long-acting beta 2 specific agonist. This study will examine GW642444M via the inhaled route and will assess the efficacy, safety, tolerability, pharmacodynamics and pharmacokinetics of a single administration of three inhaled doses (25, 100 and 400 µg) of GW642444M in persistent asthmatics. This study will be a single-centre, placebo-controlled, dose-ascending, five-way crossover in 30 asthmatic patients. Key assessments: efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics will be assessed by measurement of FEV1, blood pressure, pulse rate, 12-lead ECGs, clinical laboratory safety tests, collection of adverse events and blood samples.
DOI: 10.25934/00000412
title: A Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Investigate the Safety, Tolerability, Pharmacokinetics and Effect on Synovial Thickness and Vascularity of 28 Days Repeat Dosing of GW274150 or 7.5mg Prednisolone in RA Subjects.

description: This is an exploratory study to examine the effect of iNOS inhibition in rheumatoid arthritis patients. The study involves 28 days repeat dosing with GW274150 (dose determined by the results from a previous study), prednisolone (7.5mg) or placebo.
DOI: 10.15468/dl.4gq83t
title: Occurrence Download

description: A dataset listing the 13 species recorded in GBIF matching the query:
{
 "DatasetKey" : [
 "is Invasive plants in Luronium natans habitats in Flanders, Belgium"
 ]
}

 The dataset's 13 records were derived from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002229-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/00002060
title: A Randomised, Open Label, Five-way Crossover Study to Assess the Systemic Exposure of Fluticasone Propionate and Salmeterol From SERETIDE/ADVAIR 250HFA MDI Alone and With AeroChamber-Max Spacer and VOLUMATIC Both in Their Washed and Unwashed States in Adult Subjects With Mild or Intermittent Asthma

description: Spacers are used by people with respiratory diseases who have problems using MDIs (metered dose inhalers). This study used fluticasone propionate/salmeterol to look at the pharmacokinetic profiles produced by different spacers in their washed and un-washed states.
DOI: 10.25934/00000395
title: A Randomised, Double-blind, Placebo-controlled, Parallel Group, Repeat Dose Study to Assess the Effect of SB-480848 on Overall Asthma Control in Adult Subjects With Persistent Asthma Controlled on Stable, Low-dose, Inhaled Corticosteroids

description: The purpose of this study is to compare the effects of SB-480848 with placebo in subjects with asthma.
DOI: 10.15468/dl.kdr8cr
title: Occurrence Download

description: A dataset containing 327 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "TaxonKey is one of (Pleione bulbocodioides (Franch.) Rolfe)"
 ]
}

 The dataset includes 327 records from 17 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002239-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.dvfuhf
title: Occurrence Download

description: A dataset containing 176443 species occurrences available in GBIF matching the query:
{
 "and" : [
 "BasisOfRecord is Human Observation",
 "OccurrenceStatus is Present",
 "TaxonKey is Heracleum mantegazzianum Sommier & Levier"
 ]
}

 The dataset includes 176443 records from 421 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002230-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.11393921
title: Data for "Meat and dairy substitutes – better for health and the environment? Impacts on nutrition and sustainability; consumer perspectives; ethical and legal considerations"
title: Daten zu "Fleisch- und Milchersatzprodukte – besser für Gesundheit und Umwelt?  Auswirkungen auf Ernährung und Nachhaltigkeit, die Sicht der Konsumentinnen und Konsumenten sowie ethische und rechtliche Überlegungen"

description: Combined data reposatory for the output of the project "Meat and dairy substitutes – better for health and the environment? Impacts on nutrition and sustainability; consumer perspectives; ethical and legal considerations"

Kombiniertes Datenarchiv für die Ergebnisse des Projekts "Fleisch- und Milchersatzprodukte – besser für Gesundheit und Umwelt?  Auswirkungen auf Ernährung und Nachhaltigkeit, die Sicht der Konsumentinnen und Konsumenten sowie ethische und rechtliche Überlegungen"

The project was funded by the Foundation for Technology Assessment (TA-Swiss) "ror.org/02shtak05".

Das Projekt wurde von der Stiftung für Technologiefolgen-Abschätzung (TA-Swiss) finanziert "ror.org/02shtak05".
DOI: 10.5281/zenodo.11393922
title: Data for "Meat and dairy substitutes – better for health and the environment? Impacts on nutrition and sustainability; consumer perspectives; ethical and legal considerations"
title: Daten zu "Fleisch- und Milchersatzprodukte – besser für Gesundheit und Umwelt?  Auswirkungen auf Ernährung und Nachhaltigkeit, die Sicht der Konsumentinnen und Konsumenten sowie ethische und rechtliche Überlegungen"

description: Combined data reposatory for the output of the project "Meat and dairy substitutes – better for health and the environment? Impacts on nutrition and sustainability; consumer perspectives; ethical and legal considerations"

Kombiniertes Datenarchiv für die Ergebnisse des Projekts "Fleisch- und Milchersatzprodukte – besser für Gesundheit und Umwelt?  Auswirkungen auf Ernährung und Nachhaltigkeit, die Sicht der Konsumentinnen und Konsumenten sowie ethische und rechtliche Überlegungen"

The project was funded by the Foundation for Technology Assessment (TA-Swiss) "ror.org/02shtak05".

Das Projekt wurde von der Stiftung für Technologiefolgen-Abschätzung (TA-Swiss) finanziert "ror.org/02shtak05".
DOI: 10.15468/dl.5hzu2a
title: Occurrence Download

description: A dataset containing 378 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "TaxonKey is one of (Sinofranchetia chinensis (Franch.) Hemsl.)"
 ]
}

 The dataset includes 378 records from 17 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002240-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/00003471
title: A Randomized, Double-blind, Parallel Group Trial Comparing 12 Weeks Treatment With Tiotropium 18 mcg Daily to Combivent MDI 2 Actuations Qid in COPD Patients Previously Prescribed Combivent MDI

description: The objective of this study is to evaluate the efficacy and safety of 12 weeks treatment with tiotropium HandiHaler 18 micrograms (mcg) daily compared to Combivent Metered Dose Inhaler (MDI) Chlorofluorocarbon Inhalation Aerosol 2 actuations four times a day in Chronic Obstructive Pulmonary Disease (COPD) patients currently prescribed Combivent® MDI.
DOI: 10.25934/00001438
title: An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of GW679769 in Subjects With Hepatic Impairment

description: The purpose of the study is to evaluate how subjects with mild or moderate liver problems process or breakdown the study drug GW679769 in their bodies as compared to healthy subjects.
DOI: 10.25934/pr00007706
title: A Phase II, Open-Label Study To Assess The Efficacy and Tolerability of ZD6474 (ZACTIMA™ ) 100 mg Monotherapy In Subjects With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

description: This will be a Phase II, open label study to establish the effect of once-daily oral doses of ZD6474 100mg in subjects with locally advanced or metastatic hereditary medullary thyroid cancer in whom no standard therapeutic option is available.
DOI: 10.25934/00000382
title: An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of GW679769 in Subjects With Renal Impairment

description: The purpose of the study is to evaluate how subjects with mild or moderate kidney problems process or breakdown the study drug GW679769 in their bodies as compared to healthy subjects.
DOI: 10.25934/00000381
title: A Multi-enter, Randomized, Double-blind, Placebo-controlled, Four-way Incomplete Block Crossover Study to Examine Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single and Repeat Administration of Three Inhaled Doses (10, 15, and 20 mcg) of GSK159797

description: This study is designed to determine the efficacy and safety of a new long-acting beta-agonist for asthma patients (GSK159797) following dosing for 14 days.
DOI: 10.25934/00000372
title: A Multi-centre, Randomised, Double-blind, Placebo Controlled, Dose Ascending, Four Way Crossover Study to Examine Efficacy (FEV1), Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single and Repeat Doses of GW642444

description: This study will evaluate efficacy (FEV1), safety, tolerability, pharmacodynamics and pharmacokinetics of single and repeat inhaled doses of GW642444. This will be a multi-centre, double-blind, placebo controlled, dose ascending, four way cross-over study in approximately 28 mild to moderate asthmatic subjects. Key assessments: Efficacy, safety, tolerability, pharmacodynamics and pharmacokinetics will be assessed by measurement of FEV1, blood pressure, heart rate, 12-lead ECGs, clinical laboratory tests, collection of adverse events (AE) information and blood samples.
DOI: 10.25934/00000371
title: A Randomised, Double-blind, Placebo-controlled, Dose Ascending Crossover Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled GSK159797 Delivered by Dry Powder Inhaler in Mild to Moderate Asthmatic Subjects

description: This study was designed to test safety aspects and effects on lung function of a new dry powder version of GSK159797 for asthmatic subjects to inhale. This will allow comparison with previous studies which have only used inhalation of the drug as a vapour.
DOI: 10.25934/00000365
title: Multi-centre, Randomised, Double-blind, Placebo-controlled, Four-way Incomplete Block Crossover Study, to Examine Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single and Repeat Administration of Three Inhaled Doses (25, 100 and 400 mcg Once Daily) of GW642444

description: In order to obtain information on a wider range of doses of GW642444 (a possible new medication to treat asthma) than has been previously examined in asthmatic patients, this current study will be conducted at doses of 25 100 and 400 mcg of GW642444 and will be compared with salmeterol (50 mcg twice daily). This study will be conducted in a similar manner to a study that has already been completed (study number B2C101762) which examined repeat doses of 50, 100 and 200 mcg of GW642444. The data obtained will compliment the data from study B2C101762 and will provide confidence (or not) that the desired bronchodilation can be achieved and maintained without undesirable side effects.
DOI: 10.15468/dl.bvfxyu
title: Occurrence Download

description: A dataset containing 6354 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Ips sexdentatus (I.C.H.Boerner, 1776)"
 ]
}

 The dataset includes 6354 records from 171 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002241-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.14221531
title: PTC_Rhetorical_features

description: sample_sentences_table.csv - 350 sentences selected from the PTC corpus for annotation by 3 human annotators

annotations_table.csv - annotations by 3 human annotators of the 350 sample sentences

ChatGPT_table.csv - GPT4 annotations of the 350 sample sentences

PTC_table.csv - 20,000 sentences from the PTC corpus labeled with 18 propaganda techniques

PTC_annotations_table.csv - Fine-tuned GPT3.5 annotations of the 20,000 PTC sentences

PTC_interpretable_features_table.csv - One-hot encoded features representing the GPT3.5 annotations for 20,000 PTC sentences. Also included are other features.

For more information please see https://doi.org/10.1145/3589335.3651909
DOI: 10.5281/zenodo.14221532
title: PTC_Rhetorical_features

description: sample_sentences_table.csv - 350 sentences selected from the PTC corpus for annotation by 3 human annotators

annotations_table.csv - annotations by 3 human annotators of the 350 sample sentences

ChatGPT_table.csv - GPT4 annotations of the 350 sample sentences

PTC_table.csv - 20,000 sentences from the PTC corpus labeled with 18 propaganda techniques

PTC_annotations_table.csv - Fine-tuned GPT3.5 annotations of the 20,000 PTC sentences

PTC_interpretable_features_table.csv - One-hot encoded features representing the GPT3.5 annotations for 20,000 PTC sentences. Also included are other features.

For more information please see https://doi.org/10.1145/3589335.3651909
DOI: 10.15468/dl.zegh95
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "TaxonKey is one of (Pleione ×christianii Perner)"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002242-241125135418005/datasets/export for details.
DOI: 10.15468/dl.rzwzey
title: Occurrence Download

description: A dataset containing 799 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "TaxonKey is one of (Stauntonia angustifolia (Wall.) R.Br. ex Wall.)"
 ]
}

 The dataset includes 799 records from 20 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002243-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/00001436
title: A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis

description: This study is being conducted to see if adding GW679769 (casopitant) to ZOFRAN will significantly decrease the number of patients who experience nausea and vomiting after surgery.
DOI: 10.25934/pr00009010
title: A Multicenter, Parallel, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Moderate to Severe Plaque Psoriasis

description: The primary objective is to assess the efficacy and safety of etanercept 50 mg administered once weekly in subjects with psoriasis over 12 weeks.
DOI: 10.25934/00000332
title: A Phase III, Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of 50mg Oral Dosing With the Neurokinin-1 Receptor Antagonist GW679769 for the Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis

description: This study is being conducted to see if adding GW679769 (casopitant) to ZOFRAN will significantly decrease the number of patients who experience nausea and vomiting after surgery.
DOI: 10.15468/dl.7k3hng
title: Occurrence Download

description: A dataset containing 1193155 species occurrences available in GBIF matching the query:
{
 "ScientificName" : [
 "is one of (Quercus robur L.)"
 ]
}

 The dataset includes 1193155 records from 3655 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002234-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15156/bio/sh0212040.10fu
title: SH0212040.10FU

description: UNITE provides a unified way for delimiting, identifying, communicating, and working with DNA-based Species Hypotheses (SH). All fungal ITS sequences in the international nucleotide sequence databases are clustered to approximately the species level by applying a set of dynamic distance values (<0.5 - 3.0%). All species hypotheses are given a unique, stable name in the form of a DOI, and their taxonomic and ecological annotations are verified through distributed, web-based third-party annotation efforts. SHs are connected to a taxon name and its classification as far as possible (phylum, class, order, etc.) by taking into account identifications for all sequences in the SH. An automatically or manually designated sequence is chosen to represent each such SH. These sequences are released (https://unite.ut.ee/repository.php) for use by the scientific community in, for example, local sequence similarity searches and next-generation sequencing analysis pipelines. The system and the data are updated automatically as the number of public fungal ITS sequences grows.
DOI: 10.15156/bio/sh0212041.10fu
title: SH0212041.10FU

description: UNITE provides a unified way for delimiting, identifying, communicating, and working with DNA-based Species Hypotheses (SH). All fungal ITS sequences in the international nucleotide sequence databases are clustered to approximately the species level by applying a set of dynamic distance values (<0.5 - 3.0%). All species hypotheses are given a unique, stable name in the form of a DOI, and their taxonomic and ecological annotations are verified through distributed, web-based third-party annotation efforts. SHs are connected to a taxon name and its classification as far as possible (phylum, class, order, etc.) by taking into account identifications for all sequences in the SH. An automatically or manually designated sequence is chosen to represent each such SH. These sequences are released (https://unite.ut.ee/repository.php) for use by the scientific community in, for example, local sequence similarity searches and next-generation sequencing analysis pipelines. The system and the data are updated automatically as the number of public fungal ITS sequences grows.
DOI: 10.15468/dl.yuzwzd
title: Occurrence Download

description: A dataset containing 217354 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Pinus sylvestris",
 "OccurrenceStatus is Present",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "BasisOfRecord is one of (Human Observation, Observation, Specimen, Material sample)",
 "Year is greater than or equal to 2020",
 "Year is less than or equal to 2026"
 ]
}

 The dataset includes 217354 records from 537 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002278-260108223611665/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15156/bio/sh0212042.10fu
title: SH0212042.10FU

description: UNITE provides a unified way for delimiting, identifying, communicating, and working with DNA-based Species Hypotheses (SH). All fungal ITS sequences in the international nucleotide sequence databases are clustered to approximately the species level by applying a set of dynamic distance values (<0.5 - 3.0%). All species hypotheses are given a unique, stable name in the form of a DOI, and their taxonomic and ecological annotations are verified through distributed, web-based third-party annotation efforts. SHs are connected to a taxon name and its classification as far as possible (phylum, class, order, etc.) by taking into account identifications for all sequences in the SH. An automatically or manually designated sequence is chosen to represent each such SH. These sequences are released (https://unite.ut.ee/repository.php) for use by the scientific community in, for example, local sequence similarity searches and next-generation sequencing analysis pipelines. The system and the data are updated automatically as the number of public fungal ITS sequences grows.